Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Sales (2016 - 2025)

Nutex Health's Return on Sales history spans 15 years, with the latest figure at 0.11% for Q4 2025.

  • For Q4 2025, Return on Sales fell 28.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.21%, up 1.0%, while the annual FY2025 figure was 0.21%, 1.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.11% at Nutex Health, down from 0.39% in the prior quarter.
  • Across five years, Return on Sales topped out at 16.48% in Q1 2022 and bottomed at 14.89% in Q3 2022.
  • The 5-year median for Return on Sales is 0.0% (2021), against an average of 0.07%.
  • The largest annual shift saw Return on Sales soared 1648bps in 2022 before it tumbled -1660bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.0% in 2021, then tumbled by -113978bps to 0.2% in 2022, then tumbled by -100bps to 0.4% in 2023, then surged by 197bps to 0.39% in 2024, then crashed by -72bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Return on Sales are 0.11% (Q4 2025), 0.39% (Q3 2025), and 0.07% (Q2 2025).